Studies on Reliability and Measurement Error of Measurements in Medicine – From Design to Statistics Explained for Medical Researchers od Mokkink LB, Eekhout I, Boers M, van der Vleuten CP, de Vet HC

Polni tekst

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. od Merkel, P, Herlyn, K, Mahr, A, Neogi, T, Seo, P, Walsh, M, Boers, M, Luqmani, R

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. od Merkel, P, Aydin, S, Boers, M, Direskeneli, H, Herlyn, K, Seo, P, Suppiah, R, Tomasson, G, Luqmani, R

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. od Direskeneli, H, Aydin, S, Kermani, T, Matteson, E, Boers, M, Herlyn, K, Luqmani, R, Neogi, T, Seo, P, Suppiah, R, Tomasson, G, Merkel, P

Current status of outcome measure development in vasculitis. od Merkel, P, Aydin, S, Boers, M, Cornell, C, Direskeneli, H, Gebhart, D, Hatemi, G, Luqmani, R, Matteson, E, Milman, N, Robson, J, Seo, P, Tomasson, G

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. od Merkel, P, Seo, P, Aries, P, Neogi, T, Villa-Forte, A, Boers, M, Cuthbertson, D, Felson, D, Hellmich, B, Hoffman, G, Jayne, DR, Kallenberg, C, Krischer, J, Mahr, A, Matteson, E, Specks, U, Luqmani, R, Stone, J

Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. od Sinha, I, Altman, D, Beresford, M, Boers, M, Clarke, M, Craig, J, Alberighi, O, Fernandes, R, Hartling, L, Johnston, B, Lux, A, Plint, A, Tugwell, P, Turner, M, van der Lee, J, Offringa, M, Williamson, P, Smyth, R

Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. od Lassere, M, Johnson, K, Boers, M, Tugwell, P, Brooks, P, Simon, L, Strand, V, Conaghan, P, Ostergaard, M, Maksymowych, W, Landewe, R, Bresnihan, B, Tak, P, Wakefield, R, Mease, P, Bingham, C, Hughes, M, Altman, D, Buyse, M, Galbraith, S, Wells, G

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). od Hiligsmann, M, Cooper, C, Arden, N, Boers, M, Branco, J, Luisa Brandi, M, Bruyère, O, Guillemin, F, Hochberg, M, Hunter, D, Kanis, J, Kvien, T, Laslop, A, Pelletier, J, Pinto, D, Reiter-Niesert, S, Rizzoli, R, Rovati, L, Severens, J, Silverman, S, Tsouderos, Y, Tugwell, P, Reginster, J

HEALTH ECONOMICS IN OSTEOARTHRITIS od Hiligsmann, M, Cooper, C, Arden, N, Boers, M, Branco, J, Brandi, M, Bruyere, O, Guillemin, F, Hochberg, M, Hunter, D, Kanis, J, Kvien, T, Laslop, A, Petit-Dop, F, Pelletier, J, Pinto, D, Reiter, S, Rizzoli, R, Rovati, L, Severens, H, Silverman, S, Tsouderos, Y, Tugwell, P, Reginster, J

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. od Basu, N, Watts, R, Bajema, I, Baslund, B, Bley, T, Boers, M, Brogan, P, Calabrese, L, Cid, M, Cohen-Tervaert, J, Flores-Suarez, L, Fujimoto, S, de Groot, K, Guillevin, L, Hatemi, G, Hauser, T, Jayne, D, Jennette, C, Kallenberg, C, Kobayashi, S, Little, M, Mahr, A, McLaren, J, Merkel, P, Ozen, S

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthri... od Hiligsmann, M, Cooper, C, Guillemin, F, Hochberg, M, Tugwell, P, Arden, N, Berenbaum, F, Boers, M, Boonen, A, Branco, J, Maria-Luisa, B, Bruyère, O, Gasparik, A, Kanis, J, Kvien, T, Martel-Pelletier, J, Pelletier, J, Pinedo-Villanueva, R, Pinto, D, Reiter-Niesert, S, Rizzoli, R, Rovati, L, Severens, J, Silverman, S, Reginster, J

Uptake of the OMERACT-OARSI hip and knee osteoarthritis core outcome set: review of randomised controlled trials from 1997 to 2017 od Smith, T, Mansfield, M, Hawker, G, Hunter, D, March, L, Boers, M, Shea, B, Christensen, R, Guillemin, F, Terwee, C, Williamson, P, Roos, E, Loeser, R, Schnitzer, T, Kloppenburg, M, Neogi, T, Ladel, C, Kalsi, G, Kaiser, U, Buttel, T, Ashford, A, Mobasheri, A, Arden, N, Tennant, A, Hochberg, M, De Wit, M, Tugwell, P, Conaghan, P

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update od Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D